tm
Seeing Is Believing
tm
Seeing Is Believing
TCRX is currently covered by 2 analysts with an average price target of $5.5. This is a potential upside of $6.04 (605.13%) from yesterday's end of day stock price of $0.78.
Tscan Therapeutics's activity chart (see below) currently has 28 price targets and 34 ratings on display. The stock rating distribution of TCRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 13.1% with an average time for these price targets to be met of 44.33 days.
Highest price target for TCRX is $6, Lowest price target is $5, average price target is $5.5.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 23-Jun-2026. First documented stock forecast 10-Aug-2021.
Currently out of the existing stock ratings of TCRX, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jun-2023
$5
$3.91 (358.72%)
$5
Buy Since 13-May-2024
$6
$4.91 (450.46%)
Buy Since 06-Mar-2024
$3
$1.91 (175.23%)
What is TCRX (Tscan Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TCRX (Tscan Therapeutics) with a proven track record?
Which analyst has the current lower performing score on TCRX (Tscan Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TCRX (Tscan Therapeutics)?
Which analyst is the currently most bullish on TCRX (Tscan Therapeutics)?
Which analyst is the currently most reserved on TCRX (Tscan Therapeutics)?
